I always wonder if the people doing the hyping about various health “innovations” actually believe the hype or are just trying to make money in some way. Does that sound too naive or too cynical? Anyway, mobile health apps, while not suffering from a shortage of hype, do suffer from a shortage of research supporting value. Alas, the latest work, from the prestigious Scripps Institute, does nothing to fill the void. (Scripps Study) The authors evaluated use by adults with arrhythmia, hypertension and/or diabetes of a mobile monitoring device, compared to standard disease management for a control group. The tracking data was shared with providers, the device vendor, the health plan, the wellness program and obviously the patient, all to no avail. Over the six month study period there were no significant differences between the groups in terms of utilization or spending. There was minor evidence suggesting some better self-management of health in the intervention group. No work was done on the relative cost of the mobile device and app intervention versus standard disease management. It could be that it is a cheaper way to get the same, but not better, outcomes. I doubt that. It also could be that over a longer period of time, maybe the mobile tracking would show better differentiation. I doubt that even more. So I choose the option that people hyping this stuff are doing it to make money. I sincerely apologize to anyway offended by that and for my cynicism, which at least appears to be supported by the evidence.
Oh no, Mobile Health Isn’t Going to Save the World!
No Comments
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
March 28, 2024
More Economic News
The Congressional Budget Office is expressing increasing alarm at the federal deficit and debt situation.
Commentary
March 27, 2024
Funniest Story of the Day
Would would have thought that hail could destroy a solar farm? Certainly not the nut-case…
Commentary
March 27, 2024
What Is Going on in the US Debt Markets?
The Treasury seems determined to rely on massive amounts of short-term debt to finance our…